Move over Appen: A new artificial intelligence stock to list on the ASX – Motley Fool Australia

ASX 200
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
This technology could save some of the 9 million lives lost each year to coronary artery disease.
Image source: Getty Images
Appen Ltd (ASX: APX) is the most prominent technology company on the ASX involved in artificial intelligence (AI).
Its shareholders have suffered immensely in recent times, with the stock dropping more than 65% over the past 12 months. But even with that calamity, Appen shares have quadrupled in the last 5 years.
And it has gained more than 1,668% since listing in January 2015.
So if you’re interested in getting in from the ground level on a new AI player, there is one such company listing this month on the ASX.
Perth’s Artrya Limited (ASX: AYA) has just closed its initial public offer, with its shares due to commence general trading on the ASX on 26 November.
The company’s technology aims to automate the diagnosis of coronary artery heart disease, which can cause heart attacks.
Co-founder and managing director John Barrington said there is growing demand for improved detection of coronary artery disease.
“With 9 million people dying from the disease each year globally, the pressure on health systems is already substantial, and it’s only going to increase over the next few decades with ageing populations,” he said.
“This float will assist the company in its next stage in expansion.”
During the IPO, shares were offered for $1.35 each to raise $40 million and give Artrya a market valuation of $105.45 million.
According to the company, it has received $19 million of funding over the past 2 years from both investors and government research funds.
The Motley Fool has enquired with Artrya to confirm the progress of the IPO.
Artrya’s flagship cloud software suite is called Salix, which non-invasively detects the presence of “vulnerable plaque” in a patient’s arteries in about 15 minutes.
Such plaque is liable to rupture and cause heart attacks.
The technology was developed in conjunction with expertise from the University of Western Australia, the Harry Perkins Institute of Medical Research, and the Ottawa Heart Institute.
An “unrestricted launch” across Australia is scheduled for early in the new year while the IPO money will be used to take the technology overseas after that.
“Coronary artery disease affects an estimated 126 million people worldwide,” said Artrya chair Bernie Ridgeway.
“Of those, the majority have no warning signs of a heart attack. As the prevalence of CAD rises due to an ageing population, global health systems will have to deal with more CAD cases.”
He added that Salix is expected to disrupt the international market for Coronary Computed Tomography Angiography (CCTA) scans and Invasive Coronary Angiogram (ICA) procedures.
“An estimated 20 million cardiac CT scans are expected to be performed in both North America and Europe alone by 2025,” said Ridgeway.
“By addressing current limitations in diagnostic reporting for CAD, Salix has a valuable first-mover advantage.”
Salix was placed on the Australian Register of Therapeutic Goods (ARTG) as a Class 1 medical device in November last year.
Artrya is pursuing a subscription model for commercialisation of the software.
“This model will help Artrya penetrate the global CCTA and ICA markets because healthcare providers pay no upfront costs to use Salix,” Ridegeway said.
“Artrya believes the software-as-a-service model could deliver annuity revenue and profitable margins for the company.”
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.
See The 5 Stocks
*Returns as of August 16th 2021
Motley Fool contributor Tony Yoo owns shares of Appen Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Appen Ltd. The Motley Fool Australia owns shares of and has recommended Appen Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The iCandy Interactive Ltd (ASX: ICI) share price is surging 16.3% in afternoon trade after coming out of yesterday’s trading…
Read more »
The X2M Connect Ltd (ASX: X2M) share price is set to finish the week on a strong note. This comes after the…
Read more »
Unfortunately, the S&P/ASX 200 Index (ASX: XJO) hasn’t had the best of weeks. The ASX 200 has gone backwards by around…
Read more »
Unfortunately for investors, the Ltd (ASX: KGN) share price has put the days of its COVID-era gains behind it. Kogan, the…
Read more »
The NEXTDC Ltd (ASX: NXT) share price is trading lower following the release of its annual general meeting update. At…
Read more »
There are a lot of quality options for investors to choose from on the Australian share market. To narrow things…
Read more »
There are a number of ASX tech shares that are growing profit and/or revenue at a double-digit rate. Businesses that…
Read more »
The ELMO Software Ltd (ASX: ELO) share price is rising on Thursday after the business announced that it had extended…
Read more »
View All
Sign Up for Take Stock
Investment news, stock ideas, and more, straight to your inbox.
Get Started Investing
You can do it. Learn about investing with our Investing Education hub.
Win at Retirement
Our latest articles and strategies for the post-work life you want.
Listen to Our Podcasts
Our free podcasts, to help make the world Smarter, Happier and Richer.
Join Our Premium Community
Join our flagship membership service, Share Advisor.
To make the world Smarter, Happier, And Richer
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show and premium investing services. The Motley Fool launched its Australian presence in 2011, and since then has grown to reach over 1 million Australians.
Read more about us >

This Service provides only general, and not personalised financial advice, and has not taken your personal circumstances into account. The Motley Fool Australia operates under AFSL 400691. For more information please see our Financial Services Guide. Please remember that investments can go up and down. Past performance is not necessarily indicative of future returns. The Motley Fool Australia does not guarantee the performance of, or returns on any investment.
© 2010 – 2021 The Motley Fool Australia Pty Ltd. All rights reserved.
ACN: 146 988 052
Australian Financial Services Licence (AFSL): 400691
The Motley Fool Australia, PO Box 104, Isle of Capri, Qld 4217

Connect with Chris Hood, a digital strategist that can help you with AI.

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2021 AI Caosuo - Proudly powered by theme Octo